Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
Turning Point Therapeutics, Inc. (TPTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Bodem Barbara W. (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Disposed/sold 14,995 options to buy
@ $94.59, valued at
$1.4M
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| TOMBESI PAOLO (EVP & CFO) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Disposed/sold 29,778 shares
@ $76, valued at
$2.3M
Disposed/sold 61,200 options to buy
@ $62.63, valued at
$3.8M
Disposed/sold 58,600 options to buy
@ $37.68, valued at
$2.2M
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Sabus Steve M (SVP & Chief Commercial Officer) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Disposed/sold 36,667 shares
@ $76, valued at
$2.8M
Disposed/sold 165,000 options to buy
@ $35.37, valued at
$5.8M
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2022 |
4
| TOMBESI PAOLO (EVP & CFO) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Sold 1,183 shares
@ $74.94, valued at
$88.7k
|
|
| 06/01/2022 |
4
| Sabus Steve M (SVP & Chief Commercial Officer) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Granted 36,667 shares
@ $0
Granted 165,000 options to buy
@ $35.37, valued at
$5.8M
|
|
| 04/12/2022 |
4
| Sun Brian (SVP & General Counsel) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Granted 45,000 shares
@ $0
Granted 195,000 options to buy
@ $24.65, valued at
$4.8M
|
|
| 02/11/2022 |
4
| TOMBESI PAOLO (EVP & CFO) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Granted 16,283 shares
@ $0
Granted 58,600 options to buy
@ $37.68, valued at
$2.2M
|
|
| 02/11/2022 |
4
| Reich Siegfried (EVP & Chief Scientific Officer) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Sold 397 shares
@ $36.3, valued at
$14.4k
Granted 13,567 shares
@ $0
Granted 48,833 options to buy
@ $37.68, valued at
$1.8M
|
|
| 02/11/2022 |
4
| Partridge Andrew John (EVP & Chief Commercial Officer) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Sold 221 shares
@ $36.3, valued at
$8k
Granted 16,283 shares
@ $0
Granted 58,600 options to buy
@ $37.68, valued at
$2.2M
|
|
| 02/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2021 |
4
| TOMBESI PAOLO (EVP & CFO) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Granted 13,600 shares
@ $0
Granted 61,200 options to buy
@ $62.63, valued at
$3.8M
|
|
| 07/15/2021 |
4
| Partridge Andrew John (EVP & Chief Commercial Officer) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Sold 1,869 shares
@ $74.9, valued at
$140k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Bodem Barbara W. (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Granted 14,995 options to buy
@ $94.59, valued at
$1.4M
|
|
| 03/24/2021 |
4
| Baker Brian Lee (SVP of Finance and Admin.) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Granted 1,625 shares
@ $0
Sold 4,919 shares
@ $97.89, valued at
$481.5k
Sold 4,459 shares
@ $98.76, valued at
$440.4k
Sold 1,996 shares
@ $100.07, valued at
$199.7k
Sold 5,010 shares
@ $100.98, valued at
$505.9k
Sold 8,061 shares
@ $102.23, valued at
$824.1k
Sold 3,890 shares
@ $102.84, valued at
$400k
Sold 100 shares
@ $104.17, valued at
$10.4k
Exercised 11,904 options to buy
@ $2.19, valued at
$26.1k
Exercised 1,298 options to buy
@ $3.2, valued at
$4.2k
Exercised 4,545 options to buy
@ $5.12, valued at
$23.3k
|
|
|
|
|